Company intelligence / Profile preview
Vical Incorporated
San Diego, California, United Statesvicalhome.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Vical pioneered naked plasmid DNA delivery for vaccines and therapeutics targeting infectious diseases and cancer. Its most advanced clinical candidate, VL‑2397 for invasive aspergillosis, was discontinued after a Phase II trial due to low accrual rates. The company had previously developed multiple vaccine candidates using its proprietary platforms but did not achieve commercial approval before being acquired.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- DNA-based therapeutics (gene therapy)DNA vaccinesPlasmid DNA deliveryLipid-based formulations/adjuvants (e.g., Vaxfectin)
- Industry
- Biotech
02
Drug pipeline
17 assets16 more assets in the full pipeline.
Request access →03
Partnerships
Merck & Co.Bristol Myers SquibbBoston Scientific CorporationRhone-Poulenc RorerPfizer Inc.Kaken Pharmaceutical Co Ltd.
Beyond the preview
Go deeper on Vical Incorporated.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vical Incorporated.